And Again

When it comes to retractions, former Duke University researcher Anil Potti is the gift that keeps on giving.

As fans of scientific malfeasance no doubt recall, Potti left Duke in 2010 amidst allegations that he had manipulated data in several lung cancer biomarker studies. Duke suspended Potti (who has since taken a job at the Cancer Center of North Dakota) along with clinical trials stemming from his research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.